Summary
Updated Aug 30, 2026
Adam E. Drapczuk III is Chief Financial Officer of NEXGEL, INC. (NXGL). 1 SEC Form 4 filing on record, dated 22 November 2024. Most recent open-market trade: bought $48K of NXGL on 22 November 2024. Lifetime open-market purchases: $48K.
Recent Transactions
1Every recent SEC Form 4 transaction Adam E. Drapczuk III has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Adam E. Drapczuk III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Joseph Kieser - $1.00M of NXGL open-market activity in the last 12 months
- Adam R. Levy - $117K of NXGL open-market activity in the last 12 months
- Scott Robert Henry - $64K of NXGL open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Adam E. Drapczuk III?
Adam E. Drapczuk III is a corporate insider, tracked as Chief Financial Officer of NEXGEL, INC. (NXGL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Adam E. Drapczuk III last file a Form 4?
The only primary Form 4 on record is dated 22 November 2024.
Has Adam E. Drapczuk III been buying or selling stock?
Recorded transactions: 1 open-market purchase ($48K) and 0 open-market sales across all tracked filings.
Where can I see all of Adam E. Drapczuk III's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Adam E. Drapczuk III and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial